Ronnie Fass

Q: What Schools Are Affiliated With Ronnie Fass

Ronnie Fass is affiliated with the following schools: California Institute of Technology, University of Arizona, Stanford University, Case Western Reserve University

Ronnie Fass's AcademicInfluence.com Rankings

Ronnie Fass

Engineering

#4126

World Rank

#5293

Historical Rank

Biomedical Engineering

#241

World Rank

#248

Historical Rank

Applied Physics

#936

World Rank

#960

Historical Rank

engineering Degrees

Download Badge

Engineering

Why Is Ronnie Fass Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ronnie Fass's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effectiveness of proton pump inhibitors in nonerosive reflux disease. (2004) (432)
Non‐erosive reflux disease (NERD) — acid reflux and symptom patterns (2003) (398)
Systematic review: proton‐pump inhibitor failure in gastro‐oesophageal reflux disease – where next? (2005) (396)
The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. (1998) (392)
Clinical trial: lubiprostone in patients with constipation‐associated irritable bowel syndrome – results of two randomized, placebo‐controlled studies (2009) (369)
Management of heartburn not responding to proton pump inhibitors (2009) (308)
Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. (1998) (289)
Nonerosive Reflux Disease— Current Concepts And Dilemmas (2001) (274)
Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. (2005) (247)
Gastroesophageal reflux disease—should we adopt a new conceptual framework? (2002) (247)
Functional Esophageal Disorders. (2016) (247)
Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. (2007) (245)
Functional heartburn: the stimulus, the pain, and the brain (2002) (214)
Irritable Bowel Syndrome Patients Show Enhanced Modulation of Visceral Perception by Auditory Stress (2003) (210)
Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel. (2013) (205)
Effect of Amitryptiline on Symptoms, Sleep, and Visceral Perception in Patients With Functional Dyspepsia (1998) (205)
Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. (1999) (200)
Asia‐Pacific consensus on the management of gastroesophageal reflux disease: Update (2007) (186)
Predictors of heartburn during sleep in a large prospective cohort study. (2005) (174)
Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. (2007) (167)
Effect of Ambulatory 24-Hour Esophageal pH Monitoring on Reflux-Provoking Activities (1999) (165)
Noncardiac Chest Pain: Epidemiology, Natural Course and Pathogenesis (2011) (161)
Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn (2007) (159)
Sleep disturbances in clinic patients with functional bowel disorders (2000) (157)
Management of Gastroesophageal Reflux Disease. (2017) (150)
The Effect of Life Stress on Symptoms of Heartburn (2001) (144)
Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease (2003) (144)
Erosive Esophagitis and Barrett's Esophagus in Taiwan (A Higher Frequency than Expected) (1997) (140)
Correlation of oesophageal acid exposure with Barrett's oesophagus length (2001) (137)
Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease (2017) (133)
Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis. (2005) (131)
Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. (1998) (129)
Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. (2010) (129)
Assessment of oesophageal motor function in patients with dysphagia or chest pain — the Clinical Outcomes Research Initiative experience (2003) (126)
Current Trends in the Management of Gastroesophageal Reflux Disease (2017) (125)
Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial. (2006) (124)
Nonerosive Reflux Disease (NERD) - An Update (2010) (122)
Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro‐oesophageal reflux disease (GERD) who are resistant to conventional‐dose lansoprazole therapy—a prospective, randomized, multi‐centre study (2000) (120)
The diagnosis of gastroesophageal reflux disease. (2010) (118)
The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. (2008) (118)
Report of the Asia–Pacific consensus on the management of gastroesophageal reflux disease (2004) (116)
Feasibility and tolerability of transnasal/per‐oral placement of the wireless pH capsule vs. traditional 24‐h oesophageal pH monitoring – a randomized trial (2005) (115)
The effect of an empirical trial of high‐dose lansoprazole on symptom response of patients with non‐cardiac chest pain – a randomized, double‐blind, placebo‐controlled, crossover trial (2004) (110)
Review article: acidity and volume of the refluxate in the genesis of gastro‐oesophageal reflux disease symptoms (2007) (107)
Fatal hyperphosphatemia following Fleet Phospo-Soda in a patient with colonic ileus. (1993) (105)
Effects of gastroesophageal reflux disease on sleep and outcomes. (2009) (105)
Refractory GERD: What is it? (2008) (99)
Symptom severity and oesophageal chemosensitivity to acid in older and young patients with gastro-oesophageal reflux. (2000) (99)
Sexual Dysfunction in Patients with Irritable Bowel Syndrome and Non-Ulcer Dyspepsia (1998) (98)
Approaches to endoscopic‐negative reflux disease: part of the GERD spectrum or a unique acid‐related disorder? (2004) (97)
A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease. (2009) (94)
Increased Expression and Secretion of Interleukin-6 in Patients with Barrett’s Esophagus (2004) (94)
Relationships between sleep quality and pH monitoring findings in persons with gastroesophageal reflux disease. (2007) (93)
Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non‐erosive reflux disease (2009) (92)
Consequences of frequent nocturnal gastro‐oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity (2007) (92)
The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain. (1999) (92)
Proton Pump Inhibitor Failure—What Are the Therapeutic Options? (2009) (91)
Review article: supra‐oesophageal manifestations of gastro‐oesophageal reflux disease and the role of night‐time gastro‐oesophageal reflux (2004) (89)
Non‐cardiac chest pain: an update (2006) (89)
Prevalence of Upper Gastrointestinal Tract Findings in Patients With Noncardiac Chest Pain Versus Those With Gastroesophageal Reflux Disease (GERD)-Related Symptoms: Results from a National Endoscopic Database (2007) (89)
The Effect of Dexlansoprazole MR on Nocturnal Heartburn and GERD-Related Sleep Disturbances in Patients With Symptomatic GERD (2011) (87)
Gastroesophageal reflux disease and sleep disturbances (2012) (87)
Systematic review: the effects of carbonated beverages on gastro‐oesophageal reflux disease (2010) (85)
Comparison of Clinical Characteristics of Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Versus Those Who Fully Responded (2011) (83)
The Changing Epidemiology of Gastroesophageal Reflux Disease: Are Patients Getting Younger? (2018) (82)
Empirical Trials in Treatment of Gastroesophageal Reflux Disease (2000) (81)
Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome. (2001) (81)
Noncardiac chest pain: evaluation and treatment. (2003) (80)
The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial. (2004) (75)
Insights into gastroesophageal reflux disease-associated dyspeptic symptoms. (2011) (73)
Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease. (1999) (70)
Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors (2010) (69)
Subtypes of constipation predominant irritable bowel syndrome based on rectal perception (1998) (67)
The lower esophageal sphincter (2011) (67)
Duodenal fat intensifies the perception of heartburn (2001) (67)
Management Options for Patients With GERD and Persistent Symptoms on Proton Pump Inhibitors: Recommendations From an Expert Panel (2018) (65)
Functional Heartburn Patients Demonstrate Traits of Functional Bowel Disorder but Lack a Uniform Increase of Chemoreceptor Sensitivity to Acid (2006) (65)
New and Future Drug Development for Gastroesophageal Reflux Disease (2013) (64)
Reflux Hypersensitivity: A New Functional Esophageal Disorder (2017) (63)
Clinical consequences of silent gastroesophageal reflux disease (2006) (63)
Comparison of the Degree of Duodenogastroesophageal Reflux and Acid Reflux Between Patients Who Failed to Respond and Those Who Were Successfully Treated With a Proton Pump Inhibitor Once Daily (2009) (62)
Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure. (2007) (62)
Review article: gastro‐oesophageal reflux disease and psychological comorbidity (2009) (62)
An algorithm for diagnosis and treatment of refractory GERD. (2010) (61)
Gastroesophageal reflux disease in noncardiac chest pain. (2004) (60)
Proton-Pump Inhibitor Therapy in Patients with Gastro-Oesophageal Reflux Disease (2012) (58)
Noncardiac chest pain. (2008) (58)
Evaluation of Symptom Index in Identifying Gastroesophageal Reflux Disease-Related Noncardiac Chest Pain (2004) (57)
Pharmacological management of GERD: where does it stand now? (2011) (57)
Systematic review: the treatment of noncardiac chest pain (2012) (56)
Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release. (2012) (56)
Assessment of dietary nutrients that influence perception of intra‐oesophageal acid reflux events in patients with gastro‐oesophageal reflux disease (2006) (54)
Is there a relationship between obstructive sleep apnea and gastroesophageal reflux disease? (2003) (54)
The clinical and economic impact of competing management strategies for gastro‐oesophageal reflux disease (2002) (54)
The role of pain modulators in esophageal disorders – no pain no gain (2014) (52)
Treatment of patients with diabetic gastroparesis. (2010) (51)
Review: treatment of gastroesophageal reflux disease in the elderly. (2010) (50)
Symptom Assessment Tools for Gastroesophageal Reflux Disease (GERD) Treatment (2007) (50)
Extraesophageal and atypical manifestations of GERD (2004) (49)
Systematic review: the relationship between interstitial lung diseases and gastro‐oesophageal reflux disease (2011) (49)
A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. (2003) (49)
The extent of oesophageal acid exposure overlap among the different gastro‐oesophageal reflux disease groups (2006) (48)
Step-by-step management of refractory gastresophageal reflux disease. (2013) (48)
Partial regression of Barrett's esophagus--an inadequate endpoint. (1993) (48)
The 2011–2014 prevalence of eosinophilic oesophagitis in the elderly amongst 10 million patients in the United States (2015) (47)
Comparison of Esophageal Acid Exposure Distribution Along the Esophagus Among the Different Gastroesophageal Reflux Disease (GERD) Groups (2006) (47)
Review article: the current treatment of non‐cardiac chest pain (2016) (46)
Reduced chemoreceptor sensitivity in patients with Barrett's esophagus may be related to age and not to the presence of Barrett's epithelium. (1997) (46)
Gastroesophageal Reflux Disease (GERD) and Irritable Bowel Syndrome (IBS)—Is It One Disease or an Overlap of Two Disorders? (2009) (45)
The effect of esomeprazole 20 mg twice daily on acoustic and perception parameters of the voice in laryngopharyngeal reflux (2010) (44)
Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro‐oesophageal reflux disease groups (2007) (44)
Therapeutic options for refractory gastroesophageal reflux disease (2012) (44)
Utilisation of surgical fundoplication for patients with gastro‐oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013 (2016) (43)
Clinical trial: the effect of Johrei on symptoms of patients with functional chest pain (2009) (43)
Alternative therapeutic approaches to chronic proton pump inhibitor treatment. (2012) (42)
Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders (2019) (42)
The pathophysiology of non‐cardiac chest pain (2005) (42)
The Pathophysiological Mechanisms of GERD in the Obese Patient (2008) (42)
ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro‐esophageal reflux disease (2020) (41)
Biomarker studies in reversed Barrett's esophagus (1999) (41)
Utilization of wireless pH monitoring technologies: a summary of the proceedings from the esophageal diagnostic working group. (2013) (41)
Effect of Doses of Glucagon Used to Treat Food Impaction on Esophageal Motor Function of Normal Subjects (1999) (41)
Progression or regression of barrett's esophagus—is it all in the eye of the beholder? (2003) (41)
Night‐time and daytime atypical manifestations of gastro‐oesophageal reflux disease: frequency, severity and impact on health‐related quality of life (2007) (40)
Prevalence of Barrett's Esophagus in Hispanics Is Similar to Caucasians (1998) (40)
The proton pump inhibitor (PPI) test in GERD: does it still have a role? (2008) (40)
Distinct Phenotypic Presentations of Gastroesophageal Reflux Disease: A New View of the Natural History (2004) (39)
Increased Esophageal Chemoreceptor Sensitivity to Acid in Patients After Successful Reversal of Barrett's Esophagus (1997) (37)
The effect of a therapeutic trial of high‐dose rabeprazole on symptom response of patients with non‐cardiac chest pain: a randomized, double‐blind, placebo‐controlled, crossover trial (2005) (37)
Stimulus and site specific induction of hiccups in the oesophagus of normal subjects (1997) (37)
Sensory testing of the esophagus. (2004) (37)
Age- and gender-related differences in 24-hour esophageal pH monitoring of normal subjects (1993) (36)
Unmet Needs in the Treatment of Gastroesophageal Reflux Disease (2015) (36)
Non-erosive reflux disease (NERD) and erosive esophagitis--a spectrum of disease or special entities? (2007) (36)
The Value of Ambulatory 24 hr Esophageal pH Monitoring in Clinical Practice in Patients Who Were Referred with Persistent Gastroesophageal Reflux Disease (GERD)-Related Symptoms While on Standard Dose Anti-Reflux Medications (2005) (35)
Gastroesophageal reflux disease and sleep. (2013) (34)
Is there a relationship between obstructive sleep apnea and gastroesophageal reflux disease (2004) (34)
Effect of gastroesophageal reflux disease on sleep (2010) (32)
Impaired Sleep Quality in Crohn’s Disease Depends on Disease Activity (2013) (32)
Persistent heartburn in a patient on proton-pump inhibitor. (2008) (32)
Conscious awakenings are commonly associated with Acid reflux events in patients with gastroesophageal reflux disease. (2010) (32)
The relationship between gastroesophageal reflux disease and sleep (2009) (31)
24-hour pH monitoring in symptomatic patients without erosive esophagitis who did not respond to antireflux treatment. (1994) (31)
Gastro-Oesophageal Reflux Disease (2011) (30)
Dexlansoprazole MR – A review (2011) (30)
The role of mucin in GERD and its complications (2012) (30)
Perils of Immunohistochemistry: Variability in Staining Specificity of Commercially Available COX-2 Antibodies on Human Colon Tissue (2004) (30)
Does body mass index differ between patients with Barrett’s oesophagus and patients with chronic gastro‐oesophageal reflux disease? (2007) (29)
Extension of squamous epithelium into the proximal stomach: a newly recognized mucosal abnormality. (2000) (29)
The effect of sleep on gastrointestinal functioning in common digestive diseases. (2020) (28)
Gastroesophageal Reflux Disease: Cross-Sectional Study Demonstrating Rising Prevalence in a Chinese Population (2016) (28)
Biomarker studies in reversed Barrett's esophagus. (1999) (28)
Review article: From gastrin to gastro‐oesophageal reflux disease – a century of acid suppression (2006) (28)
Attitudes and Referral Patterns of Primary Care Physicians When Evaluating Subjects with Noncardiac Chest Pain—A National Survey (2005) (27)
Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study (2018) (27)
Gastroesophageal reflux disease revisited. (2002) (27)
Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium (2002) (27)
The relationship between eosinophilic esophagitis and esophageal cancer. (2017) (27)
Esophageal acid exposure at pH ≤ 2 is more common in Barrett's esophagus patients and is associated with oxidative stress. (2006) (27)
Gastroesophageal reflux disease and irritable bowel syndrome: A common overlap syndrome (2006) (26)
Chest pain of esophageal origin (2001) (26)
The Role of Proton Pump Inhibitors in Gastro-oesophageal Reflux Disease (2012) (26)
Assessment of 24‐h oesophageal pH monitoring should be divided to awake and asleep rather than upright and supine time periods * (2007) (26)
Effect of psychologically induced stress on symptom perception & autonomic nervous system response of patients (PTS.) With erosive esophagitis (EE) and non-erosive reflux disease (NERD) (2000) (25)
Intestinal and extraintestinal symptoms in functional gastrointestinal disorders. (1998) (25)
Abnormal Expression of Biomarkers in Incompletely Ablated Barrett’s Esophagus (2006) (25)
Recurrent peripheral arterial occlusion by leukemic cells sedimentation in acute promyelocytic leukemia. (1992) (25)
Noncardiac chest pain: diagnosis and management (2017) (25)
AGA Clinical Practice Update on Functional Heartburn: Expert Review. (2020) (24)
Increased oesophageal acid exposure at the beginning of the recumbent period is primarily a recumbent‐awake phenomenon (2010) (24)
Novel Therapies for Gastroesophageal Reflux Disease: Beyond Proton Pump Inhibitors (2020) (23)
IW-3718 Reduces Heartburn Severity in Patients With Refractory Gastroesophageal Reflux Disease in a Randomized Trial. (2020) (23)
Progression of Jackhammer Esophagus to Type II Achalasia (2015) (23)
Noncardiac chest pain: diagnostic evaluation. (2012) (23)
Functional heartburn (2005) (23)
Treatment Challenges in the Management of Gastroparesis-Related GERD (2009) (22)
New Therapies for Non-cardiac Chest Pain (2014) (22)
Esophageal motility abnormalities in cirrhotic patients before and after endoscopic variceal treatment. (1997) (21)
Nonmedical Therapeutic Strategies for Nonerosive Reflux Disease (2014) (21)
Distribution of Esophageal Motor Disorders in Diabetic Patients With Dysphagia (2017) (21)
Noncardiac Chest Pain: The Role of the Cardiologist-A National Survey (2005) (21)
Pathogenesis of diarrhea in the adult: diagnostic challenges and life-threatening conditions (2006) (21)
Functional heartburn: what it is and how to treat it. (2009) (20)
Esophagogastric junction outflow obstruction (2021) (20)
Is Proton Pump Inhibitor Testing an Effective Approach to Diagnose Gastroesophageal Reflux Disease in Patients With Noncardiac Chest Pain (2005) (20)
Update on Functional Heartburn. (2017) (20)
Reassessment of the Principal Characteristics of Gastroesophageal Reflux During the Recumbent Period Using Integrated Actigraphy-Acquired Information (2010) (20)
Barrett's oesophagus: optimal strategies for prevention and treatment. (2003) (19)
Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder. (2003) (19)
The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum (2015) (19)
Non-erosive reflux disease (NERD) — Is it really just a milld orm of gastroesophageal reflux disease (GERD)? (2001) (18)
The Relationship Between the Prevalence of Nighttime Gastroesophageal Reflux Disease and Disease Severity (2010) (18)
Treatment of Esophageal Motility Disorders Based on the Chicago Classification (2014) (18)
Pharmacokinetic comparison of orally‐disintegrating metoclopramide with conventional metoclopramide tablet formulation in healthy volunteers (2009) (18)
Night‐time intra‐oesophageal bile and acid: a comparison between gastro‐oesophageal reflux disease patients who failed and those who were treated successfully with a proton pump inhibitor (2011) (18)
Adenocarcinoma of the colon presenting as Streptococcus sanguis bacteremia. (1995) (18)
Ambulatory Esophageal pH Monitoring: New Directions (2006) (18)
Assessment of the incidence of squamous cell papilloma of the esophagus and the presence of high-risk human papilloma virus. (2016) (18)
Patients with non-cardiac chest pain (NCCP) recelving an empirical trial of high dose lansoprazole, demonstrate early symptom response. A double blind, placebo-controlled trial (2001) (18)
The role of dexlansoprazole modified-release in the management of gastroesophageal reflux disease (2017) (18)
The Relationship Between Type 2 Diabetes Mellitus and Failure to Proton Pump Inhibitor Treatment in Gastroesophageal Reflux Disease (2012) (17)
Gastro-oesophageal reflux disease (2021) (17)
Correlation of gastroesophageal reflux disease symptoms characteristics with long-segment Barrett's esophagus. (2006) (17)
Usage of Supplemental Alternative Medicine by Community-Based Patients with Gastroesophageal Reflux Disease (GERD) (2000) (17)
Riser’s reflux – an eye‐opening experience (2010) (16)
Gastroesophageal reflux disease and sleep (2007) (16)
Noncardiac chest pain: current treatment. (2007) (16)
The effect of sleep deficiency on esophageal acid exposure of healthy controls and patients with gastroesophageal reflux disease (2019) (16)
Systematic review with meta‐analysis: selective serotonin reuptake inhibitors for noncardiac chest pain (2015) (16)
Contemporary medical therapy for gastroesophageal reflux disease. (1997) (16)
Power Spectral Analysis of the Sleep Electroencephalogram in Heartburn Patients With or Without Gastroesophageal Reflux Disease: A Feasibility Study (2010) (16)
Psychological distress is not associated with treatment failure in patients with gastroesophageal reflux disease. (2013) (15)
Short segment Barrett's esophagus: relationship of age with extent of intestinal metaplasia (2000) (15)
Clinical predictors of Barrett's esophagus length. (2005) (15)
Untangling Non-erosive Reflux Disease From Functional Heartburn. (2020) (15)
The Effect of Ramelteon on Heartburn Symptoms of Patients With Gastroesophageal Reflux Disease and Chronic Insomnia: A Pilot Study (2016) (15)
Naps are associated more commonly with gastroesophageal reflux, compared with nocturnal sleep. (2015) (15)
Post-ablation biomarker abnormalities in Barrett's esophagus (BE): Are we increasing the cancer risk? (2001) (14)
The relationship between length of Barrett's oesophagus mucosa and body mass index (2015) (14)
Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium. (2002) (14)
Evaluation and diagnosis of noncardiac chest pain. (2008) (14)
Comparison of the Different Characteristics of Sensed Reflux Events Among Different Heartburn Groups (2009) (14)
Nocturnal Gastroesophageal Reflux Disease (GERD) and Sleep (2020) (13)
GERD: Are functional heartburn and functional dyspepsia one disorder? (2010) (13)
The effect of antireflux treatment on the frequency of awakenings from sleep in patients with Gastroesophageal reflux disease (2015) (13)
The effect of once daily omeprazole and succinic acid (VECAM) vs once daily omeprazole on 24‐h intragastric pH (2012) (12)
Laparoscopic Resection of a Small Bowel Lipoma with Incidental Intussusception (2010) (12)
Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett's esophagus. (2001) (12)
Clinical Characteristics and Associated Systemic Diseases in Patients With Esophageal “Absent Contractility”—A Clinical Algorithm (2019) (11)
Barrett's esophagus and other mucosal evidence of reflux in asymptomatic subjects with abnormal 24-hour esophageal pH monitoring (1994) (11)
Impact of a Formulary Change in Proton Pump Inhibitors on Health Care Costs and Patients' Symptoms (2001) (11)
Standard Triple Therapy versus Sequential Therapy in Helicobacter pylori Eradication: A Double-Blind, Randomized, and Controlled Trial (2015) (11)
Assessment of relationship between acid reflux and heartburn using receiver operating characteristic curves. (2002) (10)
Overlap Between GERD and Functional Esophageal Disorders—a Pivotal Mechanism for Treatment Failure (2019) (10)
Effect of body weight and esophageal damage on the severity of gastroesophageal reflux symptoms. Mexican GERD working group. (2009) (10)
Relief of Night-time Symptoms Associated With Gastroesophageal Reflux Disease Following 4 Weeks of Treatment With Pantoprazole Magnesium: The Mexican Gastroesophageal Reflux Disease Working Group (2013) (10)
Esophageal acid exposure at pH < or = 2 is more common in Barrett's esophagus patients and is associated with oxidative stress. (2006) (10)
Symptom indexes in refractory gastroesophageal reflux disease: overrated or misunderstood? (2011) (9)
The relationship between severity and frequency of symptoms and quality of sleep (QOS) in patients with gastroesophageal reflux disease (GERD) (2003) (9)
Discrepancies between upper GI symptoms described by those who have them and their identification by conventional medical terminology: a survey of sufferers in four countries (2016) (9)
Clinical trial: maintenance intermittent therapy with rabeprazole 20 mg in patients with symptomatic gastro‐oesophageal reflux disease – a double‐blind, placebo‐controlled, randomized study (2010) (9)
Severity of ineffective esophageal motility is associated with utilization of skeletal muscle relaxant medications (2018) (9)
295 Pilot Study of the Safety, Feasibility, and Efficacy of Continuous Glucose Monitoring (CGM) and Insulin Pump Therapy in Diabetic Gastroparesis (GLUMIT-DG): A Multicenter, Longitudinal Trial by the NIDDK Gastroparesis Clinical Research Consortium (GPCRC) (2015) (9)
Pharmacokinetics of spectinomycin in volunteers with renal insufficiency. (1981) (9)
Treatment of gastroesophageal reflux disease. (2003) (9)
Comparison of Therapeutic Strategies for Patients With Refractory Gastroesophageal Reflux Disease (GERD) – A Randomized, Double Blind, Placebo-Controlled Trial (2011) (8)
Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions—A debate: Pro (2007) (8)
The effect of antireflux treatment on patients with gastroesophageal reflux disease undergoing a mental arithmetic stressor (2011) (8)
Tests for the Evaluation of Functional Gastrointestinal Disorders (2001) (8)
Management of Gastroesophageal Reflux Disease in the Elderly Patient (2019) (8)
Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus (2002) (8)
Editorial: Healing Erosive Esophagitis With a Proton Pump Inhibitor: The More the Merrier? (2012) (8)
Esophageal mucosal impedance: is it time to forgo prolonged gastroesophageal reflux recordings? (2015) (8)
Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus (BE) (2000) (8)
An Overview of Transoral Incisionless Fundoplication and Magnetic Sphincter Augmentation for GERD. (2017) (8)
High resolution vs conventional esophageal manometry in the assessment of esophageal motor disorders in patients with non‐cardiac chest pain (2018) (8)
Multiple myeloma presenting with a colonic obstruction and bony lesions: a clinical dilemma. (2008) (8)
Transient lower oesophageal sphincter relaxation reducers – have we hit a brick wall? (2011) (7)
Sarcoidosis and giant midesophageal diverticulum. (2008) (7)
Chest pain of esophageal origin. (2001) (7)
Zollinger-Ellison syndrome: diagnosis and management. (1995) (7)
Psychological stress increases visceral sensitivity in patients with irritable bowel syndrome (IBS) but not controls (2001) (7)
The Risk of Acute Myocardial Infarction in Patients With Gastroesophageal Reflux Disease (2020) (6)
Identifying Minimal Changes in Nonerosive Reflux Disease: Is the Pay Worth the Labor? (2016) (6)
Impact of esophageal acid exposure on the endoscopic reversal of Barrett’s esophagus (2000) (6)
Nocturnal Acid Breakthrough: A Critical Assessment (2004) (6)
Noncardiac chest pain (2004) (6)
Diagnosis and Management of Functional Chest Pain in the Rome IV Era (2019) (6)
Comparison of transnasaly placed wireless pH capsule (BRAVO®) versus traditional 24-hour esophageal pH monitoring-a randomized trial (2003) (6)
S1077 Effect of Obesity On Efficacy of Maintenance Intermittent Therapy in Patients with Symptomatic Gastroesophageal Reflux Disease (sGERD) (2008) (6)
Mucin Expression in the Esophageal Malignant and Pre-malignant States: A Systematic Review and Meta-analysis (2017) (6)
Current perspectives on the diagnosis and treatment of functional esophageal disorders (2003) (6)
Comparison of Anxiety and Depression in Gastroesophageal Reflux Disease (GERD) Patients Who Failed Proton Pump Inhibitor (PPI) Therapy Versus Those Who Fully Responded to it (2011) (5)
Intravenous Glucagon in Food Impaction—Use It or Lose It? (2003) (5)
Development of quality indicators for the diagnosis and management of achalasia (2021) (5)
Eosinophilic Esophagitis Is Much Less Common Than Previously Thought: A Large, Nationwide Database Study: 102 (2013) (5)
The cost-effectiveness of the omeprazole test in noncardiac chest pain (NCCP) (1998) (5)
The Prevalence of Barrett's Esophagus in Veteran Patients with and Without GERD Symptoms Undergoing Outpatient Colonoscopy (2008) (5)
S1868 Eosinophilic Esophagitis Is Uncommon in Male-Enriched Patient Population with Refractory Heartburn (2009) (5)
Comprar Noncardiac Chest Pain: A Growing Medical Problem | Ronnie Fass | 9781597561761 | Plural Pub Inc (2007) (5)
Sarcoidosis and giant midesophageal diverticulum (2000) (5)
Sorting out the Relationship between Gastroesophageal Reflux Disease and Sleep (2021) (5)
Jackhammer Esophagus: Current Concepts and Dilemmas. (2020) (5)
SECTION II : FGIDs : DIAGNOSTIC GROUPS Esophageal Disorders (5)
Development of a Preliminary Question Prompt List as a Communication Tool for Adults With Gastroesophageal Reflux Disease (2020) (5)
Symptom Severity Influences Drug Efficacy in Women with Diabetic Gastroparesis: Results of a Phase 3 Study with Metoclopramide Nasal Spray (2017) (5)
Antidepressants for functional esophageal disorders: evidence- or eminence-based medicine? (2015) (5)
Gastroesophageal reflux: practical management of a common, challenging disorder. (1999) (5)
No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies (2021) (5)
Refractory gastroesophageal reflux disease : What next? (2005) (5)
Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions—A debate: Pro (2007) (5)
Riser's Reflux: An Eye-Opening Experience (2009) (5)
Refractory Heartburn: A Challenging Problem in Clinical Practice (2018) (5)
Nutcracker esophagus--a nut hard to swallow. (2006) (5)
Introduction: the evolving role of 24‐h oesophageal pH monitoring (2006) (4)
Noncardiac Chest Pain. (2006) (4)
Barrett’s esophagus patients are becoming younger: analysis of a large United States dataset (2020) (4)
Stretta therapy in the management of gastroesophageal reflux disease (GERD) (2019) (4)
Gastric outlet obstruction and upper gastrointestinal bleed: a PEG complication. (1995) (4)
Physicians and Patients Measure Different Dimension on Assessment for Gatroesophageal Reflux Disease-Related Symptoms (2011) (4)
Functional heartburn: misdiagnosed gastroesophageal reflux or a distinct entity? (2005) (4)
Short, spontaneous, anamnestic arousals are the most common sleep abnormality associated with nocturnal esophageal acid exposure (2003) (4)
Psychological Comorbidity and Chronic Heartburn: Which Is the Chicken and Which Is the Egg? (2017) (4)
The relationship between esophageal acid exposure, dysplasia and extent of columnar metaplasia in Barrett's esophagus (2000) (4)
Esophageal Function Abnormalities in Patients With Barrett's Esophagus. (2020) (4)
Comparison of Distribution of Intraesophageal pH During Nighttime Recumbency Among Patients With Gastroesophageal Reflux Disease (2012) (4)
875 - Iw-3718, a Novel Gastric-Retentive Bile Acid Sequestrant, Improved Heartburn and Regurgitation Symptoms in Patients with Persistent Gerd Despite PPI Treatment: A Double-Blind, Placebo-Controlled Study (2018) (4)
Advancements in the analysis of esophageal pH monitoring in GERD (2011) (4)
Bladder Cancer Presenting as Lower-GI Bleeding (2009) (4)
T2004 Actigraphy Is a Simple and Accurate Technique to Determine Esophageal Acid Exposure During Sleep in Patients Undergoing pH Testing (2008) (4)
Globus: Current Concepts and Dilemmas. (2018) (3)
Complete reversal of Barrett's esophagus: Biomarker studies indicate decreased cancer risk in a biologically normal squamous epithelium (1998) (3)
The Pathophysiology of GERD (2006) (3)
Oesophageal sensation in response to high PCO2 and acidic solutions in nonerosive reflux disease (2012) (3)
Predictors of nocturnal heartburn (NH) in a large population-based study (2003) (3)
[Ciprofloxacin in the treatment of respiratory tract infections]. (1993) (3)
The Natural Course of Gastroesophageal Reflux Disease: A Critical Appraisal of the Literature. (2020) (3)
S1891 Acid Reflux and Arousals: “Which Is the Chicken, and Which Is the Egg?” (2009) (3)
Eosinophilic Esophagitis (EoE) (2018) (3)
Colon cancer presenting as upper-GI bleeding. (2006) (3)
478 Rozerem Improves Reports of Symptoms in GERD Patients With Chronic Insomnia (2012) (3)
Nonerosive reflux disease (2006) (3)
A comparison of symptom resolution in patients diagnosed with NERD and erosive esophagitis (2003) (3)
The effect of sleep duration on symptoms perception of patients with gastroesophageal reflux disease (GERD) (2003) (3)
Clinical role of ambulatory reflux monitoring in PPI non‐responders: recommendation statements (2022) (3)
The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum (2015) (3)
The usefulness of symptom index (SI) in improving diagnosis of gastroesophageal reflux disease (GERD) related non-cardiac chest pain (NCCP) (2001) (3)
Functional heartburn (2014) (3)
GERD: Surgery or medical therapy for patients with GERD? (2013) (3)
Irritable bowel syndrome: A global view (2003) (3)
The relationship between nocturnal esophageal acid exposure and nocturnal heartburn in patients with gastroesophageal reflux disease (GERD) (2003) (2)
Dexlansoprazole MR for Treatment for Nocturnal Heartburn in Patients with Symptomatic Nonerosive GERD: 29 (2009) (2)
Distribution of acid exposure along the esophagus of patients with erosive esophagitis (EE) versus those with non-erosive reflux disease (NERD) (2003) (2)
Carbonation: A Review of Sensory Mechanisms and Health Effects (2014) (2)
Durability of Esophageal Motor Disorders Identified on High-Resolution Esophageal Manometry: A Case Series (2020) (2)
Comparison of the Degree of Nighttime Duodenogastroesophageal (DGER) and Acid Reflux Between Patients Who Failed and Those Who Were Successfully Treated With a Proton Pump Inhibitor (PPI) Once Daily (2011) (2)
New Frontiers in Gastroesophageal Reflux Disease (2002) (2)
Barrett's esophagus: are Caucasians the only ethnic group at risk? (1999) (2)
STRESS AND GASTROESOPHAGEAL REFLUX DISEASE (2018) (2)
Intraduodenal fat alters perceptual and autonomic responses to acid perfusion of the esophagus in GERD patients (1998) (2)
Unexplained noncardiac chest pain. Authors'reply (1997) (2)
Commentary: the proton pump inhibitor test – does it have a role in eosinophilic oesophagitis? (2014) (2)
Best Practices in Treatment of Laryngopharyngeal Reflux Disease: A Multidisciplinary Modified Delphi Study (2022) (2)
The Overlap Between GERD and Functional Bowel Disorders - When East Meets Rome (2010) (2)
Mo1088 The Effect of Anti-Reflux Treatment on Acid Reflux and Conscious Awakenings From Sleep in Patients With Gastroesophageal Reflux Disease (2012) (2)
Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain (NCCP) due to gastroesophageal reflux disease (GERD) (1998) (2)
The clinical and economic impact of competing management strategies for gerd (2000) (2)
Correlation between the height of abnormal acid reflux and the length of Barrett's esophagus (2000) (2)
Endoscopic Approaches for the Treatment of Gastroesophageal Reflux Disease. (2019) (2)
Corrigendum: Physicians and Patients Measure Different Dimension on Assessment for Gatroesophageal Reflux Disease-related Symptoms (2012) (2)
W1814 The Effect of Johrei (Energy Healing) Versus Wait-List On Symptoms of Patients with Functional Chest Pain (Fcp) of Presumed Esophageal Origin - a Randomized Trial (2008) (2)
The Value of Upper Endoscopy in Patients with Gastroesophageal Reflux Disease (GERD) Who Failed Proton Pump Inhibitor (PPI) Therapy (2006) (2)
Editorial: management of eosinophilic oesophagitis – efficacy vs. effectiveness (2016) (2)
Mucin Expression in the Esophageal Malignant and Premalignant States (2017) (2)
Frequent Nighttime Symptoms and Increased GERD Symptom Severity Are Associated with Impaired Functioning: 883 (2007) (2)
Commentary: functional dyspepsia ‐ is acupuncture the solution? (2012) (2)
IW-3718, a Novel Gastric-Retentive Bile Acid Sequestrant, Improved Symptoms of Refractory GERD in a Double-Blind, Placebo-Controlled Phase 2a Study: 1661 (2015) (2)
Esophageal Manifestations of Dermatological Conditions (2018) (1)
Sa1038 DEVELOPMENT OF QUALITY INDICATORS FOR THE DIAGNOSIS AND MANAGEMENT OF ACHALASIA (2020) (1)
Esophageal Motility Disorders (2018) (1)
Nonerosive Reflux Disease (NERD) (2018) (1)
T1906 The Differential Effect of Sleep Deprivation Versus Good Sleep on Esophageal Acid Exposure in Normal Subjects (2010) (1)
Clinical Characteristics of GERD Patients Who Incompletely Responded to PPI Therapy (2011) (1)
Impact of Proton Pump Inhibitor Dosing on PPI Utilization Patterns Among Patients with Gastroesophageal Reflux Disease: 1123 (2009) (1)
Alteration in Integrated Relaxation Pressure During Successive Swallows in Subjects With Normal Manometry Versus Those With Esophagogastric Junction Outflow Obstruction (2021) (1)
Prevalence of Upper Gastrointestinal Tract Findings in Patients with Heartburn Who Failed PPI Treatment Versus Those Off Antireflux Treatment (2009) (1)
Pill esophagitis (2000) (1)
The Discrepancy Between Subjective and Objective Clinical Endpoints in Gastroesophageal Reflux Disease (2022) (1)
The Relationship Between Length of Barrett’s Esophagus Mucosa and Body Mass Index: 9 (2014) (1)
Effect of esophageal location on chemosensitivity to acid in patients with Barrett's esophagus (1998) (1)
Novel Upcoming Therapies (2016) (1)
The Effect of Pantoprazole Versus Placebo On Gastroesophageal Reflux Disease (GERD) Related Symptoms Other Than Heartburn (2008) (1)
Gastroesophageal Reflux Disease. (2012) (1)
Prokinetic agents and antiemetics (2014) (1)
536 Severity of Ineffective Esophageal Motility Is Associated With Utilization of Muscle Relaxants (2016) (1)
Association Between Sleep Disturbances and Gastroesophageal Reflux Disease‐Related Medical Costs Among GERD Patients: 1124 (2009) (1)
686 A High Acid Reflux Recording During the Beginning of the Supine Period Is a Sleep Initiation Phenomenon (2009) (1)
Progression of Jackhammer Esophagus to Achalasia: Author’s Reply (2016) (1)
Is sham acupuncture necessary?: authors’ reply (2008) (1)
The relationship between gastroesophageal reflux disease and autism spectrum disorder in adult patients in the United States (2021) (1)
Effect of Dexlansoprazole MR on Improving Work Productivity and Daily Activities in Patients with Symptomatic Nonerosive GERD: 31 (2009) (1)
Diagnostic Accuracy of the Proton Pump Inhibitor Test in Gastroesophageal Reflux Disease and Noncardiac Chest Pain (2022) (1)
Comparison of Acid Reflux Characteristics throughout the Sleep Period among the Different Gastroesophageal Reflux Disease (GERD) Groups: 11 (2006) (1)
Maintenance of Heartburn Symptom Relief in Patients Stepped-Down from Twice-Daily Proton Pump Inhibitor to Once-Daily Dexlansoprazole MR: 13 (2011) (1)
ORIGINAL ARTICLES—ALIMENTARY TRACT Conscious Awakenings Are Commonly Associated With Acid Reflux Events in Patients With Gastroesophageal Reflux Disease (2010) (1)
Proton‐pump inhibitor use and the development of new ischemic heart disease in non‐cardiac chest pain patients (2020) (1)
Effects of Dexlansoprazole MR on Sleep Quality and Health-Related Quality of Life (HRQOL) in Patients with Symptomatic Nonerosive GERD: 30 (2009) (1)
Esophageal Hypocontractile Disorders and Hiatal Hernia Size Are Predictors for Long Segment Barrett’s Esophagus (2023) (1)
Once daily esomperazole and twice daily lansoprazole for nocturnal heartburn in patients with GERD (2003) (1)
Development of a Preliminary Question Prompt List as a Communication Tool for Adults With Achalasia (2022) (1)
Esomeprazole 40mg once daily and lansoprazole 30mg twice daily for heartburn symptoms in patients with resistant GERD (2003) (1)
Update on symptomatic GERD. (2004) (1)
Retroperitoneal liposarcoma presenting with bilateral leg lymphedema--case report. (1990) (1)
Sleep Deficiency Is Associated With Exacerbation of Symptoms and Impairment of Anorectal and Autonomic Functions in Patients With Functional Constipation (2022) (1)
Current perspectives on the diagnosis and treatment of functional esophageal disorders (2007) (1)
12 – Impact of Iw-3718, a Novel Gastric-Retentive Bile Acid Sequestrant, on a Spectrum of Gerd Symptoms in Patients with Persistent Gerd Receiving Ppis – Results from a Double-Blind, Placebo-Controlled Study (2019) (1)
Is PPI test an effective approach to diagnose gastroesophageal reflux disease in patients with non cardiac chest pain? A meta-analysis (2004) (1)
Prevalence of Esophageal Findings in Patients with Non-Cardiac Chest Pain (NCCP) - Among a Large Multi-Center Consortium (2006) (1)
Symptomatic Patients with Erosive Esophagitis Demonstrate Reduced Delta Electroencephalographic Activity during Sleep Compared to Those without Erosive Esophagitis or Abnormal Esophageal Acid Exposure: 68 (2006) (1)
Value of the Proton Pump Inhibitor (PPI) Test for Patients with GERD, NCCP, and Extra-Esophageal GERD: A Meta-Analysis: 433 (2016) (1)
Squamous islands in Barrett's esophagus: Biomarker studies suggest continued increased cancer risk (1998) (1)
[The effect of alternative therapies on symptoms of patients with functional chest pain--pilot study with Johrei healing technique]. (2009) (1)
966 NAPS are More Commonly Associated With Gastroesophageal Reflux as Compared With Sleep Time (2012) (1)
IL-6 expression and secretion is increased in patients with Barrett's esophagus (2003) (1)
Question Prompt List as a Communication Tool for Adults With Gastroesophageal Reflux Disease (2021) (1)
Chapter Sixty-Eight – Noncardiac chest pain (2006) (1)
Functional Heartburn, Nonerosive Functional Heartburn, Nonerosive Reflux Disease, and Reflux Reflux Disease, and Reflux Esophagitis Are All Distinct Esophagitis Are All Distinct Conditions—A Debate: Pro Conditions—A Debate: Pro (2007) (1)
W1089 Comparison of Clinical Characteristics of Patients With Gastroesophageal Reflux Disease (GERD) Who Failed Versus Those Who Fully Responded to Proton Pump Inhibitor (PPI) Therapy (2010) (1)
THE PROTON PUMP INHIBITOR TEST IN NON-CARDIAC CHEST PAIN: USE IT OR LOSE IT? (2005) (1)
12. Relationship between Gastroesophageal Reflux Disease and Sleep (2013) (0)
S0363 Gastroesophageal Reflex Disease (GERD) Complications in Adults With Autism (2020) (0)
Inter‐ and intra‐rater agreement of interpretation of functional lumen imaging probe in healthy subjects (2022) (0)
Tu1880 Gastro-Oesophageal Reflux Disease -A Decade Later: Rising Prevalence in a Chinese Population (2014) (0)
The Contribution of High-Resolution versus Conventional Esophageal Manometry to the Assessment of Esophageal Motor Disorders in Patients With Non-Cardiac Chest Pain (NCCP): 384 (2017) (0)
Chapter 9: Esophageal Disorders (2016) (0)
Durability and Predictability of Treatment Response to Lubiprostone in Patients With Constipation-Predominant Irritable Bowel Syndrome: 1792 (2015) (0)
Reply: To PMID 24907504. (2015) (0)
The effect of clinically used doses of glucagon on esophageal motility of normal subjects (1998) (0)
The impact of switching gastroesophageal reflux disease (GERD) patients from omeprazole to lansoprazole on health care utilization and patient treatment outcomes (2000) (0)
THE ASSOCIATION BETWEEN GASTROESOPHAGEAL REFLUX DISEASE AND OBSTRUCTIVE SLEEP APNEA: A META-ANALYSIS AND SYSTEMATIC REVIEW (2022) (0)
T1115 Comparison of Topographic Distribution of Intraesophageal pH During Nighttime Among Patients With Gastroesophageal Reflux Disease (GERD) (2010) (0)
S405 Major Depressive Disorder and Generalized Anxiety Disorder Are Associated With Gastroesophageal Reflux Disease and Its Complications: A Nationwide Study (2021) (0)
S3136 The Association Between Epilepsy and Gastroesophageal Reflux Disease (2020) (0)
II : FGIDs : DIAGNOSTIC GROUPS Esophageal Disorders (0)
Maintenance Intermittent Therapy with Rabeprazole 20 mg in Patients with Symptomatic GERD (sGERD): 169 (2006) (0)
S0424 Patients With Gastroesophageal Reflux Disease and Diffuse Esophageal Spasm (DES) Have a Higher Risk of Developing Barrett’s Esophagus (2020) (0)
The Relationship Between the Esophageal Tissue Content of Neurotensin and the Presence or Absence of Esophageal Inflammation (2004) (0)
Letter: oesophageal eosinophilia must be excluded before determining prevalence of eosinophilic oesophagitis – authors’ reply (2015) (0)
M1869 The Effect of Antireflux Versus Placebo On Perception of Intraesophageal Acid in Patients with Gastroesophageal Reflux Disease (GERD) Undergoing a Mental Arithmetic Stressor Test–a Randomized, Double-Blind, Placebo-Controlled, Parallel Trial (2009) (0)
S384 Menopause Is an Important Risk Factor for GERD and Its Complications in Women (2021) (0)
S781 Comparison of Surgical History and Reported Symptoms Between Patients With Concomitant IBD and IBS and Those With IBD Alone (2022) (0)
The Relationship Between Type 2 Diabetes Mellitus and Proton Pump Inhibitor Failure in Patients With Gastroesophageal Reflux Disease: 2499 (2015) (0)
389 Are Proton Pump Inhibitors Associated With an Increased Risk in Developing Ischemic Heart Disease in Non-Cardiac Chest Pain Patients? (2019) (0)
Contents Vol. 24, 2006 (2006) (0)
Sa1078 - The Changing Epidemiology of Gastroesophageal Reflux Disease (GERD)- are We Seeing Younger Patients? (2018) (0)
New horizons in the medical treatment of gastro-oesophageal reflux disease. (2003) (0)
Sa143 THE RISK OF COVID-19 IS HIGHER IN FEMALES USING PROTON PUMP INHIBITORS (2021) (0)
690 Conscious Arousals Associated with Acid Reflux Are Very Common During Sleep But Are Rarely Symptomatic (2009) (0)
Gastroesophageal Reflux Disease (GERD) (2018) (0)
Print and Media Review (2008) (0)
Esophageal tissue content of neurotensin (NT) is significantly higher in patients with nonerosive reflux disease (NERD) as compared to those with erosive esophagitis (2001) (0)
Assessment of Risk Factors for Non-Variceal Upper GI Bleeding (UGIB) (2006) (0)
S0386 Newly Diagnosed Barrett's Esophagus After Bariatric Surgery (2020) (0)
304 Utilization of Surgical Fundoplication in GERD Patients in the United States Has Been Rapidly Declining in the Last Decade (2015) (0)
GERD: Shifting Trends, Increasing Prevalence in the Younger Population: 26 (2013) (0)
Long term follow up of dysplasia in patients with short segment barretts esophagus (SSBE) (1997) (0)
Advances in the Management of Gastroesophageal Reflux Disease (1999) (0)
Gastrectomy Increases Risk for Esophageal Adenocarcinoma and Gastric Cardia Adenocarcinoma: An Explorys Study: 392 (2017) (0)
The prevalence of barretts esophagus in hispanic patients undergoing endoscopy is similar to causasian patients (1997) (0)
W1099 Vecam™: Superior Control of Nighttime Acid Secretion, Towards a Novel Treatment for Nighttime Heartburn (2010) (0)
Mo1102 Bioelectric Impedance and Anthropometric Measurements in Patients With GERD (2015) (0)
Duration of Heartburn Is the Only Symptom Characteristic That Distinguishes Between Patients with Long Segment (LSBE) and Those with Short Segment Barrett's Esophagus (SSBE) (2004) (0)
Tu1335 SLEEP DISORDERS ARE VERY COMMON IN PATIENTS WITH BARRETT'S ESOPHAGUS (2020) (0)
Effect of the transcutaneous electrical stimulation system on esophageal-acid exposure in patients non-responsive to once-daily proton-pump inhibitor: proof-of-concept study (2021) (0)
Laparoendoscopic removal of eroded gastric banding after multiple surgeries for band slippage (2018) (0)
Patients with Nocturnal Heartburn and Acid Regurgitation Report More Frequent Nighttime and Daytime Atypical GERD Symptoms: 1059 (2006) (0)
Graft Versus Host Disease (2018) (0)
Assessment of symptom severity and chemosensitivity to acid in elderly versus young patients with gastroesophageal reflux disease (GERD) (1998) (0)
Reduced Mental and Physical Functioning among Patients with Frequent Atypical GERD Symptoms: 1061 (2006) (0)
AbstractShort segment Barrett’s esophagus (SSBE): relation of age with extent of intestinal metaplasia (2000) (0)
Noncardiac chest pain and proton pump inhibitors. Authors' reply (2006) (0)
The Relationship between Atypical GERD Manifestations and Sleep Impairment: 884 (2007) (0)
Clinical predictive factors for long-segment Barrett's esophagus (2003) (0)
THE ASSOCIATION BETWEEN HORMONE REPLACEMENT THERAPY AND THE INCIDENCE OF ESOPHAGEAL CANCER IN POST-MENOPAUSAL WOMEN: A SYSTEMATIC REVIEW AND META-ANALYSIS (2022) (0)
Nocturnal Gastroesophageal Reflux Disease (2004) (0)
Mo1636 - Will They Show? Predicting Nonattendance for Scheduled Screening Colonoscopies (2018) (0)
Characterization of patients with heartburn who have a normal endoscopy and 24 hour pH monitoring (2001) (0)
S413 The Interaction Effect of Gender and Socio-Economic Status on the Incidence of COVID-19 in Patients With Gastroesophageal Reflux Disease: A Population-Based Study (2021) (0)
The Problem of Heartburn, and Atypical Chest Pain (2011) (0)
Author and Subject Index (2004) (0)
Gastroesophageal reflux: a neuronal disorder? by David P. Hirsch, University of Amsterdam, Amsterdam, 2001, 157 pp., ISBN 90-9014448-X (2002) (0)
PGI15 MENTAL AND PHYSICAL FUNCTIONING REDUCED AMONG PATIENTS WITH FREQUENT ATYPICAL GERD SYMPTOMS (2007) (0)
Noncardiac Chest Pain and Proton Pump Inhibitors—Reply (2006) (0)
Heartburn and Noncardiac Chest Pain (2012) (0)
T2003 Comparison of the Extent of Duodenogastroesophageal Reflux (Dger) and Acid Reflux Between Patients Who Failed Symptomatically and Those Who Demonstrated Complete Symptom Relief On Proton Pump Inhibitor (PPI) Once Daily (2008) (0)
The effect of repetitive balloon distensions on sensory intensity rating in the proximal and distal esophagus of normal subjects and patients with gastroesophageal reflux disease (GERD) (1998) (0)
Clinical differences between patients with endoscopy-negative reflux disease (ENRD) and patients with functional heartburn (FH) (2000) (0)
S410 Diagnostic Accuracy of the Proton Pump Inhibitor Test in Patients With Erosive and Non-Erosive Reflux Disease: A Systematic Review and Meta-Analysis (2021) (0)
Potential underligying mechanisms for proton-pump inhibitor failure in patients with gastroesophageal reflux disease (2007) (0)
Prevalence of Sleep Impairment among Adults with GERD: 885 (2007) (0)
Treatment of Nonerosive Reflux Disease (Beyond Proton Pump Inhibitors) (2010) (0)
P53 mutation in short segment Barrett's esophagus (SSBE) (1998) (0)
Esophageal Acid Exposure During Sleep Is Different in Younger Patients As Compared to Older Patients with Gastroesophageal Reflux Disease (GERD) (2007) (0)
“Let’s Make Your Clinic Visit a Little Simpler”—Development of a Question Prompt List for Adult Patients With Gastroesophageal Reflux Disease: a Modified Delphi Study (2019) (0)
SUBMITTED, NOT PRESENTED: LIVER (2021) (0)
Short segment Barrett's esophagus (SSBE): variation in length with endoscopic follow up (2000) (0)
Symptom Pattern At Baseline Predicts Treatment Response in Erosive Esophagitis Patients (2006) (0)
Once-daily esomeprazole and twice-daily lansoprazole in controlling epigastric pain and acid regurgitation in patients with resistant GERD (2003) (0)
Su1094 EGJ Outflow Obstruction and Minor Motility Disorders Are Common in Diabetic Patients With Esophageal Symptoms (2016) (0)
ESOPHAGEAL SENSATION???A LUMINAL VIEW (2006) (0)
Letter: is there a relationship between Barrett's oesophagus length and body mass index? Authors' reply (2015) (0)
S537 Comparison of Disorders of Gut-Brain Interaction and Gastrointestinal Motility Between Patients With and Without IBD (2022) (0)
Comparison of Sensed Acid Reflux Event Characteristics among the Different GERD Groups: 43 (2007) (0)
CLINICAL IMPLICATIONS OF CHRONIC THERAPY FOR GERD (2009) (0)
Sa1881 Barrett's Esophagus - Is the Patient Population Becoming Younger? (2015) (0)
S3262 Hypotensive Motility Disorders Increase the Risk for Long Segment Barrett's Esophagus (2021) (0)
EP1119: THE CLINICAL VALUE OF RANDOM ESOPHAGEAL BIOPSIES IN PATIENTS WITH DYSPHAGIA AND NORMAL ENDOSCOPY (2022) (0)
Frequent Nocturnal Complaints of Heartburn and Acid Regurgitation Are Associated with Higher GERD Severity Scores: 1058 (2006) (0)
Rings and Webs (2019) (0)
Session 4: Long-term medical management (2001) (0)
NGM 2010 HOST ANMS (2010) (0)
S1635 Gender-Related Difference on Demographics and Comorbidities of Gastroparesis (2022) (0)
Impact of Gastroesophageal Reflux Disease (GERD) on Likelihood of Sleep Disturbances: 1122 (2009) (0)
S1063 The Effect of Esomeprazole 20 Mg Twice Daily Versus Placebo On Acoustic and Perception Parameters of the Voice in Patients Diagnosed with GERD-Related Posterior Laryngitis (GPL) (2008) (0)
Short segment Barrett's esophagus (SSBE): relation of age with extent of intestinal metaplasia (2000) (0)
Mo1528 HIGH RATE OF CONCORDANCE BETWEEN PHYSICIANS AND PATIENTS ON SHARED DECISION QUESTIONS FOR DEVELOPMENT OF A GASTROESOPHAGEAL REFLUX DISEASE (GERD) QUESTION PROMPT LIST (QPL) (2020) (0)
S449 Variations in Esophageal Nocturnal Impedance Values Throughout the Sleep Period in Gastroesophageal Reflux Disease Patients (2021) (0)
152 IS CHRONIC USE OF RANITIDINE ASSOCIATED WITH AN INCREASED RISK OF DEVELOPING GASTROINTESTINAL MALIGNANCIES? (2020) (0)
The Relationship Between Type 2 Diabetes Mellitus and Refractory Gastroesophageal Reflux Disease: 28 (2011) (0)
Sa252 CHARACTERIZATION OF TREATMENT PRACTICES FOR PATIENTS WITH NEWLY DIAGNOSED H. PYLORI INFECTION: A US POPULATION-BASED STUDY USING CLAIMS AND ELECTRONIC MEDICAL RECORD DATA (2021) (0)
Finally, duration of the omeprazole test is limited to 7 days; if the patient responds positively, the dose of omeprazole can be appropri- ately adjusted afterwards. (1999) (0)
Comparison of Proximal Migration of Sensed Reflux Events Among the Different GERD Groups (2007) (0)
The Effect of Additional Acupuncture Versus Doubling the Proton Pump Inhibitor (PPI) Dose on Symptoms Report of Patients Who Continued To Be Symptomatic on Standard Dose PPI - A Randomized Trial: 12 (2006) (0)
ARE INTENSIVISTS OVER-PRESCRIBING ACID SUPPRESSIVE THERAPY FOR STRESS ULCER PROPHYLAXIS TO PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT? A SYSTEMATIC REVIEW AND META-ANALYSIS (2022) (0)
Clinical implications of chronic therapy for GERD. Preface. (2009) (0)
Augmenter of Liver Regeneration Links Mitochondrial Function to Steatohepatitis and Hepatocellular Carcinoma (2015) (0)
Gastroesophageal Reflux During Sleep – Sleepless Nights are Common: 91 (2008) (0)
Su1206: ASSOCIATION OF FUNCTIONAL HEARTBURN WITH ESOPHGEAL MORPHOLOGICAL ALTERNATION (2022) (0)
S422 Patient Perspective and Feedback on a Dysphagia-Specific Question Prompt List (QPL) Communication Tool (2022) (0)
PGD4: THE CLINICAL AND ECONOMIC IMPACT OF COMPETING MANAGEMENT STRATEGIES FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD) (2000) (0)
Dysphagia, GER, and Aspiration in the Elderly (2012) (0)
S412 Diagnostic Accuracy of the Proton Pump Inhibitor Test in Patients With Gastroesophageal Reflux Disease and Non-Cardiac Chest Pain: A Systematic Review and Meta-Analysis (2021) (0)
S386 Comparison of Clinical Characteristics Between Refractory Heartburn Versus Refractory Gastroesophageal Reflux Disease Patients (2021) (0)
S388 Eosinophilic Esophagitis Patients With Celiac Disease Have Higher Rates of Comorbid Atopic Conditions (2021) (0)
S425 Hormone Replacement Therapy Is Associated With Reduced Risk of Squamous Cell Carcinoma of the Esophagus in Post-Menopausal Women: A Systematic Review and Meta-Analysis (2022) (0)
Tu1137: RALOXIFENE IS ASSOCIATED WITH INCREASED RISK OF GERD, BARRETT'S ESOPHAGUS AND ESOPHAGEAL STRICTURE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS (2022) (0)
Development and modification of a dysphagia question prompt list to improve patient-physician communication: Incorporating both esophageal expert and patient perspectives. (2023) (0)
Assessment of the relationship between obstructive sleep apnea (OSA) and gastroesophageal reflux disease (GERD) (2001) (0)
A NEW LOOK AT AN OLD CONTROVERSY: PPIs VERSUS ANTI-REFLUX SURGERY IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD) AND SEVERE ESOPHAGITIS (2004) (0)
Unexplained Noncardiac Chest Pain (1997) (0)
Subject Index Vol. 24, 2006 (2006) (0)
Frequency of heartburn and severity of dysphagia are the only symptom characteristics that distinguish long segment Barrett’s from short segment Barrett’s esophagus (2004) (0)
Endoscopic Radiofrequency (Stretta) in the Management of Gastroesophageal Reflux Disease (GERD) (2021) (0)
Curbside Consultation in GERD: 49 Clinical Questions, Phillip Katz (Ed.). Slack, Inc, Thorofare, New Jersey (2008), www.slackbooks.com, 175 pp. $79.95, ISBN 1-0155-6428-189. Web site for ordering: (2009) (0)
S441 The Association Between Chronic PPI Use and COVID-19 Infection (2021) (0)
Comparison of lower pH values in the esophagus of patients with Barrett's esophagus versus those with erosive esophagitis (2003) (0)
Comprar Noncardiac Chest Pain | Ronnie Fass | 9781597561761 | Plural Pub Inc (2007) (0)
Utilization of Over the Counter (OTC) Medication for Symptom Control in GERD Patients on Prescription (RX) Medication (2005) (0)
S3383 Gap in Care: Follow-Up of Incidental Hepatic Steatosis on Imaging in an Urban Safety-Net Hospital (2021) (0)
Commentary: effect of pregabalin on acid‐induced oesophageal hypersensitivity (2012) (0)
Chapter 1: Esophageal Disorders (2016) (0)
S457 Comparison of the Prevalence of Psychiatric Disorders Among Refractory GERD, Functional Heartburn and Reflux Hypersensitivity (2022) (0)
Esophageal Anatomy and Physiology (2018) (0)
The Effect of High Pco2 Solution on Esophageal Acid Sensation in Nonerosive Reflux Disease Patients (2011) (0)
Patients vote with their feet for ‘On demand’ rabeprazole in the maintenance treatment phase of reflux oesophagitis: author’s reply (2010) (0)
Chemoreceptor sensitivity and esophageal motor function before and after reversal of Barrett's espohagus (BE) with endoscopic multipolar electrocoagulation (MPEC) (2001) (0)
Author Index and Subject Index (2001) (0)
The Value of Proton Pump Inhibitor (PPI) Therapy for Patients With Non-cardiac Chest Pain (NCCP): A Meta-analysis: 1701 (2015) (0)
872 Asymptomatic Awakenings From Sleep Due to Acid Reflux are Significantly More Common in Older Versus Younger Patients With GERD (2010) (0)
Increasing BMI Is Associated with Classic and Atypical GERD Symptoms: 1060 (2006) (0)
Functional gastrointestinal disorders: Venlafaxine is a potential therapy for functional chest pain (2011) (0)
663 – “Let's Make Your Clinic Visit a Little Simpler” - Development of a Question Prompt List for Adults with Gastroesophageal Reflux Disease: A Modified Delphi Study (Poster Presentation) (2019) (0)
Mo1397: WENSHENJ-JIANPI IMPROVES BOWEL FUNCTION, VISCERAL HYPERSENSITIVITY, ANXIETY/DEPRESSION-LIKE BEHAVIORS, AND FMRI BRAIN ACTIVITY IN A RODENT MODEL OF IBS-D (2022) (0)
S366 Efficacy of Topical Corticosteroids in Achieving Histologic, Clinical, and Endoscopic Remission in Patients With Eosinophilic Esophagitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2021) (0)
Sa178 THE IMPACT OF ACTIVE CANNABIS USE ON ESOPHAGEAL MOTILITY. (2021) (0)
Night‐time intra‐oesophageal bile and acid exposure in GERD patients failing PPI therapy: authors’ reply (2011) (0)
Editors’ Recognition Awards for Distinction in Reviewing in 2017 (2018) (0)
S0387 Alteration in Integrated Residual Pressure (IRP) During Successive Swallows in Esophagogastric Junction Outflow Obstruction (EGJOO) as Compared With Normal Subjects (2020) (0)
The Necessity of Validated Questionnaires: Determining Accurate Responses to Proton Pump Inhibitor Use (2012) (0)
Interrater Reliability of Functional Lumen Imaging Probe (FLIP) Panometry and High-Resolution Manometry for Assessment of Esophageal Motility Disorders. (2023) (0)
Patients with Severe GERD Report More Frequent Nighttime and Daytime Atypical GERD Symptoms: 1062 (2006) (0)
Accepting the Torch. (2017) (0)
Reflux hypersensitivity - what is in the name? (2018) (0)
Vascular Abnormalities of the Esophagus (2018) (0)
EVALUATION OF THE DISCREPANCY BETWEEN THE EFFICACY OF TOPICAL CORTICOSTEROIDS IN ACHIEVING HISTOLOGIC, CLINICAL, AND ENDOSCOPIC REMISSION IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2022) (0)
Gastroesophageal reflux: a neuronal disorder? (2002) (0)
Management Options for Patients With Proven GERD and Persistent Symptoms on Proton Pump Inhibitors: 415 (2017) (0)
Sa087 DEVELOPMENT OF A QUESTION PROMPT LIST (QPL) AS A COMMUNICATION TOOL FOR ADULTS WITH DYSPHAGIA: A MODIFIED DELPHI STUDY (2021) (0)
Sa1032 DEVELOPMENT OF A PRELIMINARY QUESTION PROMPT LIST AS A COMMUNICATION TOOL FOR ADULTS WITH ACHALASIA: A MODIFIED DELPHI STUDY (2020) (0)
Thanks to Reviewers (2016) (0)
Gastrointestinal Motility - New Directions? (2006) (0)
Non-Cardiac Chest Pain: An Update (2011) (0)
S409 Gender-Specific Susceptibility to SARS-CoV-2 Infection Among Patients With Gastroesophageal Reflux Disease (GERD) Using Proton Pump Inhibitors (PPI): A Nationwide Study (2021) (0)
S424 Online Patient Education for Gastroesophageal Reflux Disease – Are Patients Being Misinformed? (2022) (0)
Other Esophageal Disorders (2018) (0)
S385 Comparison of Acidic Versus Weakly Acidic Reflux Distribution During Sleep Time in Patients with Refractory GERD (2021) (0)
Tu1328: SLEEP DEFICIENCY IS ASSOCIATED WITH EXACERBATION OF SYMPTOMS AND IMPAIRMENT OF ANORECTAL AND AUTONOMIC FUNCTIONS IN PATIENTS WITH FUNCTIONAL CONSTIPATION (2022) (0)
S355 Effect of Hormone Replacement Therapy on Gastroesophageal Reflux Disease and Barrett’s Esophagus in Post-Menopausal Women (2021) (0)
Endoscopic Anti-Reflux Procedures: Ready for Clinical Use? (2021) (0)
Sa1006 - Telephone Encounters and their Effect on No-Show Rates in an Outpatient Endoscopy Center: A Prospective Randomized Trial (2018) (0)
Corrigendum (2019) (0)
Asia-Pacific consensus on the management of gastroesophageal reflux disease: Update (Journal of Gastroenterology and Hepatology 22, (8-22) DOI: 10.1111/j.1440-1746.2007.05249.x) (2008) (0)
ARE ALL PROTON PUMP INHIBITORS THE SAME (2004) (0)
The Effect of Poor Quality of Sleep On Esophageal Acid Exposure (2006) (0)
S3137 Diagnostic Accuracy of Proton Pump Inhibitor Test for Diagnosis of Gastro-Esophageal Reflux Disease (GERD): A Meta-Analysis of Clinical Trials (2020) (0)
The effect of combined oral contraceptives and Nexplanon on gastroesophageal reflux disease in premenopausal women: A nationwide database analysis (2023) (0)
The Requisites in gastroenterology: esophagus and stomach: by David Katzka and David Metz. 200 pp. $89.95. New York, New York, Elsevier, inc., 2004. isbn 0323018866. web address for ordering: www.elsevier.com (2004) (0)
Will They Show? Predictors of Nonattendance for Scheduled Screening Colonoscopies at a Safety Net Hospital (2020) (0)
Tu1138: NEXPLANON IS ASSOCIATED WITH GERD AND ITS COMPLICATIONS IN PREMENOPAUSAL WOMEN (2022) (0)
S0446 The Association Between Multiple Sclerosis and Esophageal Dysmotility: A Nationwide Population-Based Study (2020) (0)
S411 Effect of Histamine-2 Receptor Blockers Use on COVID-19 Susceptibility in Patients With Gastroesophageal Reflux Disease (GERD): A Population-Based Study (2021) (0)
An ulcer negative for Helicobacter pylori and nonsteroidal anti-inflammatory drugs? Consider herbal treatment as the culprit! (2009) (0)
Image of the Month: Answer (2004) (0)
726 The Value of Endoscopy, Proton Pump Inhibitor Therapy, and Pain Modulators in Patients With Non-Cardiac Chest Pain (NCCP): Systematic Review and Meta-Analysis (2014) (0)
S0411 Proton Pump Inhibitor Test for GERD-Related Non-Cardiac Chest Pain – Meta-Analysis of Controlled Clinical Trials (2020) (0)
Sa1208: INTER- AND INTRA-RATER AGREEMENT OF FLIP™ NORMATIVE MEASUREMENTS IN HEALTHY SUBJECTS (2022) (0)
Sa1381 The Mechanism of Nighttime Reflux: Does Acid Reflux Trigger an Awakening or an Awakening Trigger Acid Reflux? (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ronnie Fass?

Ronnie Fass is affiliated with the following schools:

California Institute of Technology
University of Arizona
Stanford University
Case Western Reserve University

Ronnie Fass's Academic­Influence.com Rankings

Why Is Ronnie Fass Influential?

Ronnie Fass's Published Works

Published Works

What Schools Are Affiliated With Ronnie Fass?

Ronnie Fass's AcademicInfluence.com Rankings